Results 151 to 160 of about 173,572 (181)

Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer

Clinical Nutrition, 2020
Systemic inflammation arising from complex host-tumour interactions is considered the seventh hallmark of cancer. The aim of this study was to assess the clinical feasibility of our newly developed 'lymphocyte-to-C-reactive protein (CRP) ratio' (LCR) and 'lymphocyte CRP score' (LCS) for predicting short- and long-term outcomes in patients with gastric ...
Yoshinaga Okugawa, Yuji Toiyama, Akira Yamamoto, Tsunehiko Shigemori, Takashi Ichikawa, Chengzeng Yin, Akihiro Suzuki, Hiroyuki Fujikawa, Hiromi Yasuda, Junichiro Hiro, Shigeyuki Yoshiyama, Masaki Ohi, Toshimitsu Araki, Donald C. McMillan, Masato Kusunoki   +14 more
openaire   +4 more sources

Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma

International Journal of Clinical Oncology, 2021
Systemic inflammation has been correlated with worse survival for some cancers. We evaluated prognostic values of various inflammatory factor combinations in patients who underwent resections for hepatocellular carcinoma (HCC).We retrospectively analysed 306 consecutive patients with HCC who underwent curative liver resections.
Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, Akinari Morinaga, Tomonari Shimagaki, Huanlin Wang, Takeshi Kurihara, Takeo Toshima, Yoshihiro Nagao, Noboru Harada, Yoshinao Oda, Masaki Mori   +12 more
openaire   +2 more sources

Could lymphocyte to C‐reactive protein ratio predict the prognosis in patients with gastric cancer?

ANZ Journal of Surgery, 2021
AbstractBackgroundDevelopment or progression of inflammation in neoplastic diseases is known to be part of the disease. Lymphocyte to C‐reactive protein ratio (LCR) is a new indicator showing the inflammatory state. The aim of this study is to show the clinical importance of the relationship between the preoperative LCR and the prognosis of patients ...
Yavuz Selim, Angin, Murat, Yildirim, Fatih, Dasiran, Ismail, Okan   +3 more
openaire   +2 more sources

Lymphocyte-to-C-reactive Protein Ratio: a New Biomarker to Predict Perforation in Acute Appendicitis

Indian Journal of Surgery, 2021
The objective of this study is to examine the success of lymphocyte-to-C-reactive protein ratio (LCR) in the differentiation of acute appendicitis and perforated appendicitis. In this case series analysis, the data of patients who had operated with acute appendicitis between 2014 and 2020 were analyzed and histopathologically divided into two groups ...
Celil Ugurlu, Murat Yildirim, Alpaslan Ozturk, Ozhan Ozcan, Mustafa Sami Bostan, Salih Yilmaz   +5 more
openaire   +1 more source

Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer

Hepatobiliary & Pancreatic Diseases International, 2022
Inflammation is often related to cancer, and several inflammatory scores have been established to predict the prognosis of various types of cancer. Our study aimed to determine the prognostic value of the preoperative lymphocyte to C-reactive protein ratio (LCR) for predicting postoperative outcomes in patients with resectable gallbladder cancer (GBC ...
Wen-Yan, Yao, Xiang-Song, Wu, Shi-Lei, Liu, Zi-You, Wu, Ping, Dong, Wei, Gong   +5 more
openaire   +2 more sources

Lymphocyte-To-C-Reactive Protein Ratio Is A Potential New Prognostic Biomarker for Patients with Lung Cancer

Biomarkers in Medicine, 2020
Aim: To compare and evaluate the prognostic value of various pretreatment combinations of inflammatory factors in patients with lung cancer (LC). Materials & methods: This study enrolled 1005 patients with LC and categorized into a discovery cohort and a validation cohort.
Yuan He, Rui Gong, Kun-Wei Peng, Li-Zhen Liu, Li-Yue Sun, Hai-Yun Wang   +5 more
openaire   +2 more sources

Lymphocyte‐to‐C‐Reactive Protein Ratio as a Novel Marker for Predicting Oncological Outcomes in Patients with Esophageal Cancer

World Journal of Surgery, 2021
AbstractBackgroundEsophageal cancer has a poor prognosis because of its rapid progression and early and extensive lymph node metastasis. Simple, objective indicators for predicting long‐term outcomes are needed to select optimal perioperative treatment and appropriate follow‐up for patients with esophageal cancer.
Masashi, Takeuchi, Hirofumi, Kawakubo, Shota, Hoshino, Satoru, Matsuda, Shuhei, Mayanagi, Tomoyuki, Irino, Kazumasa, Fukuda, Rieko, Nakamura, Norihito, Wada, Yuko, Kitagawa   +9 more
openaire   +2 more sources

Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer

Surgical Oncology, 2022
There are still no useful predictive biomarkers for esophago-gastric junction (EGJ) cancer. We compared 15 candidate inflammation-based markers and investigated the clinical impact of the selected biomarker.One hundred three patients with EGJ cancer between 2002 and 2020 were enrolled, and associations between clinicopathological data and inflammatory ...
Masahiro, Tsujiura, Akira, Yamamoto, Hiroki, Imaoka, Tadanobu, Shimura, Takahito, Kitajima, Yuhki, Morimoto, Mikio, Kawamura, Hiromi, Yasuda, Yoshiki, Okita, Takeshi, Yokoe, Yoshinaga, Okugawa, Masaki, Ohi, Yuji, Toiyama   +12 more
openaire   +2 more sources